Transvenous Phrenic Nerve Stimulation for Treatment of Central Sleep Apnea: Five-Year Safety and Efficacy Outcomes

BACKGROUND: The remedē System Pivotal Trial was a prospective, multi-center, randomized trial demonstrating transvenous phrenic nerve stimulation (TPNS) therapy is safe and effectively treats central sleep apnea (CSA) and improves sleep architecture and daytime sleepiness. Subsequently, the remedē S...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Nat Sci Sleep
Главные авторы: Costanzo, Maria Rosa, Javaheri, Shahrokh, Ponikowski, Piotr, Oldenburg, Olaf, Augostini, Ralph, Goldberg, Lee R, Stellbrink, Christoph, Fox, Henrik, Schwartz, Alan R, Gupta, Sanjaya, McKane, Scott, Meyer, Timothy E, Abraham, William T
Формат: Artigo
Язык:Inglês
Опубликовано: Dove 2021
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8092633/
https://ncbi.nlm.nih.gov/pubmed/33953626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NSS.S300713
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы